KZR
Kezar Life Sciences Inc
Price:  
5.83 
USD
Volume:  
5,558.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KZR WACC - Weighted Average Cost of Capital

The WACC of Kezar Life Sciences Inc (KZR) is 7.5%.

The Cost of Equity of Kezar Life Sciences Inc (KZR) is 8.00%.
The Cost of Debt of Kezar Life Sciences Inc (KZR) is 7.00%.

Range Selected
Cost of equity 6.90% - 9.10% 8.00%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.6% - 8.4% 7.5%
WACC

KZR WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.66 0.76
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.10%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.23 0.23
Cost of debt 7.00% 7.00%
After-tax WACC 6.6% 8.4%
Selected WACC 7.5%